Stroke Thrombolysis in Patients Taking Ticagrelor –Two Successful Cases and a Review of the Literature

Ticagrelor is a novel antiplatelet agent that is frequently used for secondary prevention in coronary artery disease and has emerging evidence in stroke after the recent results of SOCRATES and THALES trials. The use of intravenous thrombolysis with alteplase in acute ischemic stroke (AIS) patients on ticagrelor is a topic of debate as the safety profile of ticagrelor in this setting is not well established.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research